Balligand, Thomas

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers

Defour, J.-P., Leroy, E., Dass, S., Balligand, T., Levy, G., Brett, I. C., Papadopoulos, N., Mouton, C., Genet, L., Pecquet, C., et al. (2023) · eLife

Receptor Mechanisms and SignalingPlatelet Disorders and Treatments

Cited by 10